Reviparin in acute myocardial infarction

Comment

Andrew T Yan et al. JAMA. 2005.

. 2005 Jun 1;293(21):2595; author reply 2595-6.

doi: 10.1001/jama.293.21.2595-b.

No abstract available

Comment on

Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators. Yusuf S, et al. JAMA. 2005 Jan 26;293(4):427-35. doi: 10.1001/jama.293.4.427. JAMA. 2005. PMID: 15671427 Clinical Trial.

Reviparin in acute myocardial infarction.
Buccelletti F. Buccelletti F. JAMA. 2005 Jun 1;293(21):2595. doi: 10.1001/jama.293.21.2595-a. JAMA. 2005. PMID: 15928275 No abstract available.
Use of anticoagulants in ST-segment elevation myocardial infarction patients; a focus on low-molecular-weight heparin.
Gurm HS, Eagle KA. Gurm HS, et al. Cardiovasc Drugs Ther. 2008 Feb;22(1):59-69. doi: 10.1007/s10557-007-6077-4. Epub 2007 Dec 29. Cardiovasc Drugs Ther. 2008. PMID: 18165932 Review.
Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators. Yusuf S, et al. JAMA. 2005 Jan 26;293(4):427-35. doi: 10.1001/jama.293.4.427. JAMA. 2005. PMID: 15671427 Clinical Trial.
Low-molecular weight heparins.
Talley JD. Talley JD. J Ark Med Soc. 1997 Apr;93(11):555-6. J Ark Med Soc. 1997. PMID: 9114648 No abstract available.
Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
Rubboli A, Ottani F, Capecchi A, Brancaleoni R, Galvani M, Swahn E. Rubboli A, et al. Cardiology. 2007;107(2):132-9. doi: 10.1159/000094659. Epub 2006 Jul 21. Cardiology. 2007. PMID: 16864962 Review.